For the year ending 2025-12-31, TRDA has $377,378K in assets. $71,245K in debts. $90,394K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 90,394 | |||
| Marketable securities | 205,304 | |||
| Restricted cash, current portion | 658 | |||
| Collaboration receivable | 1,177 | |||
| Prepaid expenses and other current assets | 8,719 | |||
| Total current assets | 306,252 | |||
| Property and equipment, net | 7,313 | |||
| Restricted cash, net of current portion | 3,292 | |||
| Right-of-use assets, operating leases | 60,451 | |||
| Other non-current assets | 70 | |||
| Total assets | 377,378 | |||
| Accounts payable | 2,289 | |||
| Accrued expenses and other current liabilities | 17,682 | |||
| Income taxes payable | 0 | |||
| Operating lease obligations, current portion | 4,138 | |||
| Deferred revenue, current portion | 342 | |||
| Total current liabilities | 24,451 | |||
| Operating lease obligations, net of current portion | 46,794 | |||
| Deferred revenue, net of current portion | 0 | |||
| Total liabilities | 71,245 | |||
| Common stock, par value 0.0001 150,000,000 shares authorized 38,284,221 shares issued and outstanding as of december31, 2025 and 37,585,944 shares issued and 37,574,538 shares outstanding as of december31, 2024 | 4 | |||
| Additional paidin capital | 578,571 | |||
| Accumulated other comprehensive income (loss) | 652 | |||
| Accumulated deficit | -273,094 | |||
| Total stockholders equity | 306,133 | |||
| Total liabilities and stockholders equity | 377,378 | |||
Entrada Therapeutics, Inc. (TRDA)
Entrada Therapeutics, Inc. (TRDA)